Skip to main content

Day: July 8, 2020

Safe Orthopaedics announces its revenues for the 1st half of 2020

Revenues of 1,731 M€ for the first half of 2020, a decline of only 15% despite the impact of the sanitary crisisSignificant resumption of business on direct distribution markets in June 2020Confirmation of the creation of a French leading group for ready-to-use technologies for spinal surgery, submitted to the Annual General Meeting on July 24th, 2020 for approvalEragny-sur-Oise, France, July 8th, 2020, 17h45 CEST – Safe Orthopaedics (FR0013467123 – ALSAF), a company specializing in the design and marketing of ready-to-use technologies for spinal surgeries, delivering the safest treatment of spinal fractures urgently treated, today announces its revenues for the first half of 2020.“Safe Orthopaedics ends the first Semester of 2020 with a global decrease of half-year sales of only 15% compared to the first Semester 2019, despite a...

Continue reading

Safe Orthopaedics annonce son chiffre d’affaires du 1er semestre 2020

Chiffre d’affaires de 1,731M€ au 1er semestre 2020, en contraction de seulement 15%, malgré l’impact de la crise sanitaireReprise significative de l’activité sur les marchés en commercialisation directe dès le mois de juin 2020Confirmation de la constitution d’un groupe leader français du prêt à l’emploi en chirurgie orthopédique. Le projet sera soumis en AG le 24 juillet.Eragny-sur-Oise, France, le 8 juillet 2020 à 17h45 CEST – Safe Orthopaedics (FR0013467123 – ALSAF), société́ spécialisée dans la conception et commercialisation de technologies prêtes-à-l ’emploi pour la chirurgie du dos, particulièrement sécurisantes pour les fractures vertébrales traitées en urgence, annonce aujourd’hui son chiffre d’affaires semestriel clos au 30 juin 2020.«Safe Orthopaedics clôture le premier semestre 2020 avec une contraction des ventes semestrielles...

Continue reading

LUMIBIRD : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE

Lannion, le 8 juillet 2020– 17h45LUMIBIRD : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITEAu titre du contrat de liquidité portant sur les actions de la société LUMIBIRD (FR0000038242 – LBIRD FP) confié à Louis Capital Markets UK LLP, les moyens suivants figuraient au compte de liquidité ouvert dans les livres d’Oddo BHF SCA à la date du 30/06/2020 :32 372 titres330 327,11 euros en espèceAu cours du 1er semestre 2020, il a été négocié un total de :Il est rappelé que lors du bilan semestriel du 31/12/2019, les moyens suivants figuraient au compte de liquidité :13 868 titres193 895,34 euros en espèceIl est rappelé que lors de la mise en place du nouveau contrat de liquidité au 04/03/2019, les moyens suivants ont été mis à disposition :5 683 titres319 729,50 euros en espèceLUMIBIRD est un des plus grands spécialistes mondiaux du laser. Fort de...

Continue reading

BUREAU VERITAS : Bilan semestriel du contrat de liquidité au 30 juin 2020

Communiqué de presseNeuilly-sur-Seine, France – 8 juillet 2020Bilan semestriel du contrat de liquiditéAu titre du contrat de liquidité confié par la société BUREAU VERITAS à EXANE BNP PARIBAS, en date de dénouement du 30 juin 2020, les moyens suivants figuraient au compte de liquidité :278 261 titres BUREAU VERITAS2 893 295 eurosAu cours du 1er semestre 2020, il a été négocié un total de :Achat : 2 150 645 (5 126 transactions) pour un total de 43 598 625 eurosVente : 2 003 282 titres (5 401 transactions) pour un total de 40 728 217 eurosIl est rappelé que :Lors du dernier bilan semestriel, en date de dénouement au 31 décembre 2019, les moyens suivants figuraient au compte de liquidité :125 898 titres BUREAU VERITAS5 893 077 eurosAu cours du 2nd semestre 2019, il a été négocié un total de :Achat : 1 854 324 titres (3 774 transactions)...

Continue reading

Freddie Mac Prices $936 Million Multifamily K-Deal, K-F80

MCLEAN, Va., July 08, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) has priced a new offering of Structured Pass-Through Certificates (K Certificates), which includes a class of floating rate bonds indexed to the Secured Overnight Financing Rate (SOFR). The approximately $936 million in K Certificates (K-F80 Certificates) are expected to settle on or about July 16, 2020. The K-F80 Certificates are backed by floating-rate multifamily mortgages with 10-year terms, which are currently LIBOR-based.K-F80 includes one class (Class AL) of senior bonds indexed to LIBOR and another class (Class AS) of senior bonds indexed to SOFR. Freddie Mac will provide a basis risk guarantee on Class AS that covers any floating interest rate basis risk if the value of SOFR exceeds the value of LIBOR.DetailsCo-Lead Managers and Joint Bookrunners: Goldman...

Continue reading

OR appeals verdict of District Court of Reykjavík

Orkuveita Reykjavíkur has today assigned their general counsel to appeal the verdict of the District Court of Reykjavík to Landsréttur Appeal Court, wherein the company is made to pay the amount of 740.000.000 ISK plus interest as settlement of derivative contracts agreed with Glitnir Bank during the years before the collapse of the banking system in Iceland.The verdict does not consider the main arguments of Orkuveita Reykjavíkur in this matter. Firstly, that Glitnir Holdco the plaintiff, is not legally involved in this case since the claim was assigned to the Icelandic State in 2016. Secondly, an Appraisal report by Court-Appointed Assessors was presented to the court on behalf of OR stating that the bank was in fact insolvent as of January 2008 and existing contracts thus defaulted at the time and derivative contracts dating after...

Continue reading

Albioma : 2019 dividend – Results of the option for the payment in the form of new shares

Press releaseParis La Défense, 8 July 20202019 dividendResults of the option for the payment in the form of new sharesAlbioma announces that the option for the payment of the dividend for the 2019 financial year resulted in the subscription of 281,450 new shares, i.e. 71.67 % of the coupons reinvested.The option was to be exercised from 15 June to 6 July 2020. It offered the possibility to have 50% of the dividend for the 2020 financial year paid in the form of new shares, issued at a price of €27.77 each. The 2019 dividend was set at €0.70. Shares held under registered form for two calendar years also benefited, within the limit of 0.5% of the capital, from a 10% dividend premium (ie a dividend of 0.77 euro).The newly issued shares shall be admitted for trading on Euronext Paris on 10 July 2020, alongside existing shares (ISIN FR0000060402)...

Continue reading

ALBIOMA : Dividende 2019 – Résultats de l’option pour le paiement en actions

Communiqué de presseParis La Défense, le 8 juillet 2020Dividende de l’exercice 2019Résultats de l’option pour le paiement en actions nouvellesAlbioma annonce que l’option pour le paiement en actions nouvelles du dividende de l’exercice 2019 s’est traduite par la souscription de 281 450 actions nouvelles, soit un taux de réinvestissement de 71,67 %.L’option, qui pouvait être exercée du 15 juin au 6 juillet 2020, permettait d’obtenir le paiement de 50 % du dividende de l’exercice 2019 en actions nouvelles, émises à un prix unitaire de 27,77 euros. Le dividende de l’exercice 2019 était fixé à 0,70 euro par action. Les actions justifiant d’une inscription au nominatif depuis deux années civiles bénéficiaient par ailleurs, dans la limite de 0,5 % du capital, à une majoration du dividende de 10 % (soit un dividende de 0,77 euro).Les actions...

Continue reading

Hearing Aids Market Size to Reach USD 14.45 Billion by 2026: Rising Prevalence of Hearing Impairment to Aid in Expansion, says Fortune Business Insights™

Pune, July 08, 2020 (GLOBE NEWSWIRE) — The global hearing aids market is projected to witness notable growth and reach USD 14.45 billion by the end of 2026 on account of the increasing issues of hearing impairment especially among the geriatric population. A hearing aid is a tiny electronic device that helps people to hear sounds at a higher intensity than normal. A recent report by Fortune Business Insights titled, “Hearing Aids Market Size, Share & Industry Analysis, By Product (Hearing Devices, Hearing Implants), By Patient Type (Adult, Pediatric), By Distribution Channel (OTC (Over the Counter), Medical Channel/ Hospital Pharmacies, Private Practice/ Retail Pharmacies) and Regional Forecast, 2019-2026,” the value of this market was USD 8.39 billion in the year 2018. The forecast period is set between 2019 to 2026 and the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.